ATS 2018 International Conference - Mobile

Improvements in Asthma-Related Quality of Life Observed Within 4 Weeks of Treatment with Tezepelumab [Board No. 418]

Location: Board no. 418

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

22

2:15 PM

4:15 PM

Speaker(s)/Author(s)

René van der Merwe

MBChB, MFPM
MedImmune

Liangwei Wang

Ph.D.
MedImmune

Sean O'Quinn

MPH
AstraZeneca

Stephanie L. Roseti

RN, MSN, APN-BC
MedImmune

May Mo

MS
Amgen Inc

Jane R. Parnes

MD
Amgen Inc

Jonathan Corren

MD
David Geffen School of Medicine at UCLA

Janet M. Griffiths

PhD
MedImmune

View Abstract

Improvements in Asthma-Related Quality of Life Observed Within 4 Weeks of Treatment with Tezepelumab

Parent Sessions

C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
05-22-2018 2:15 PM - 4:15 PM